Malvern Panalytical, manufacturer of analytical systems, and Concept Life Sciences (CLS), a contract research organisation, have today announced a full business integration. The integration will expand Amplify Analytics, the companies’ existing analytical instrument and service relationship, to include CLS’s chemistry and biology services. Both entities are operating businesses within the Spectris Group.

Mark Fleiner, president of Malvern Panalytical, expressed excitement about the opportunities presented by the integration: “Everyone at Malvern Panalytical is deeply committed to supporting our customers in delivering the pharmaceutical and agrochemical products needed to improve our health and quality of life.

“During this pandemic, we’ve already seen how, together with our customers, we can play a small but important role in enabling the development of vital medicines and treatments that can make a big contribution to the health of the world. We are all delighted to build significantly on our capability to achieve this with the passion, expertise and commitment of the combined Malvern Panalytical and CLS teams.”

The integration builds on the companies’ launch of Amplify Analytics last year – a range of flexible services designed to help pharmaceutical organisations identify new drug candidates and de-risk the process of developing robust formulations. The collaboration’s success has been demonstrated in the significant value delivered to clients, providing the insight needed to bring pharmaceutical products to market quickly and efficiently.

Although the two businesses’ union will bring new approaches to client support, CLS’s strong commitment to its existing clients remains unchanged. Mark Carnegie-Brown, president of CLS, confirmed: “We have made sure that there is a seamless transition to the Malvern Panalytical platform for all our clients, free from changes to key contacts and existing service and confidentiality agreements.

“Our clients should not notice any changes to how we interact with them, but they will see expanded access to all capabilities and expertise across CLS and Malvern Panalytical. Our excited and enthused combined teams are eager to explore the unique opportunities delivered by our integration.”